JP2023523373A5 - - Google Patents
Info
- Publication number
- JP2023523373A5 JP2023523373A5 JP2023509465A JP2023509465A JP2023523373A5 JP 2023523373 A5 JP2023523373 A5 JP 2023523373A5 JP 2023509465 A JP2023509465 A JP 2023509465A JP 2023509465 A JP2023509465 A JP 2023509465A JP 2023523373 A5 JP2023523373 A5 JP 2023523373A5
- Authority
- JP
- Japan
- Prior art keywords
- total
- cmai
- patient
- approximately
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063016270P | 2020-04-27 | 2020-04-27 | |
| US63/016,270 | 2020-04-27 | ||
| PCT/US2021/029246 WO2021222145A1 (en) | 2020-04-27 | 2021-04-26 | Methomethods of treating agitation associated with alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023523373A JP2023523373A (ja) | 2023-06-02 |
| JP2023523373A5 true JP2023523373A5 (enExample) | 2024-04-19 |
Family
ID=75914613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509465A Pending JP2023523373A (ja) | 2020-04-27 | 2021-04-26 | アルツハイマー病に関連する激越を治療する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230270738A1 (enExample) |
| EP (1) | EP4142729A1 (enExample) |
| JP (1) | JP2023523373A (enExample) |
| KR (1) | KR20230016636A (enExample) |
| CN (1) | CN115734787A (enExample) |
| AU (1) | AU2021263354A1 (enExample) |
| BR (1) | BR112022021535A2 (enExample) |
| CA (1) | CA3176234A1 (enExample) |
| IL (1) | IL296977A (enExample) |
| MX (1) | MX2022013427A (enExample) |
| PH (1) | PH12022552764A1 (enExample) |
| TW (1) | TW202203922A (enExample) |
| WO (1) | WO2021222145A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2792662T3 (da) | 2007-05-01 | 2016-07-25 | Concert Pharmaceuticals Inc | Morphinanforbindelser |
| CN115322150B (zh) * | 2021-05-11 | 2024-05-28 | 深圳信立泰药业股份有限公司 | 氘代右美沙芬氢溴酸盐的固体及其制备方法和医药用途 |
| KR20240110812A (ko) * | 2021-10-27 | 2024-07-16 | 아바니르 파마슈티컬스, 인코포레이티드 | 알츠하이머병과 관련된 불안을 치료하는 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206248A (en) | 1992-03-27 | 1993-04-27 | Smith Richard A | Method for reducing emotional lability |
| US20160143901A1 (en) * | 2006-02-03 | 2016-05-26 | Avanir Pharmaceuticals, Inc. | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of agitation in dementia |
| MX370608B (es) | 2007-05-01 | 2019-12-18 | Concert Pharmaceuticals Inc | Compuestos de morfinano. |
| TWI869633B (zh) * | 2014-09-14 | 2025-01-11 | 美商阿瓦尼爾製藥股份有限公司 | 用於治療失智症中躁動行為之包含右旋美索芬(dextromethorphan)化合物及奎尼丁(quinidine)的藥學組成物 |
-
2021
- 2021-04-26 WO PCT/US2021/029246 patent/WO2021222145A1/en not_active Ceased
- 2021-04-26 EP EP21725652.8A patent/EP4142729A1/en not_active Withdrawn
- 2021-04-26 JP JP2023509465A patent/JP2023523373A/ja active Pending
- 2021-04-26 CA CA3176234A patent/CA3176234A1/en active Pending
- 2021-04-26 CN CN202180045685.XA patent/CN115734787A/zh active Pending
- 2021-04-26 BR BR112022021535A patent/BR112022021535A2/pt not_active IP Right Cessation
- 2021-04-26 PH PH1/2022/552764A patent/PH12022552764A1/en unknown
- 2021-04-26 MX MX2022013427A patent/MX2022013427A/es unknown
- 2021-04-26 AU AU2021263354A patent/AU2021263354A1/en not_active Abandoned
- 2021-04-26 KR KR1020227041229A patent/KR20230016636A/ko active Pending
- 2021-04-26 US US17/921,579 patent/US20230270738A1/en not_active Abandoned
- 2021-04-26 IL IL296977A patent/IL296977A/en unknown
- 2021-04-27 TW TW110115202A patent/TW202203922A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Doberstyn et al. | Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine—sulfadoxine | |
| Baudraz‐Rosselet et al. | Treatment of onychomycosis with terbinafine | |
| JPH05506007A (ja) | ２’３’―ジデオキシイノシンによるヒトのレトロウィルス感染症の治療 | |
| JP2006503839A (ja) | 真菌感染の処置のためのポサコナゾールの使用 | |
| Simon et al. | Treatment of hypertensive and hypercholesterolaemic patients with the triple fixed combination of atorvastatin, perindopril and amlodipine: the results of the CORAL study | |
| Wilairatana et al. | Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. | |
| US20220031686A1 (en) | Treatment of Migraine | |
| JP2016531949A (ja) | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 | |
| JP2023541048A5 (enExample) | ||
| JP2024539476A5 (enExample) | ||
| US20060069155A1 (en) | Method for reducing exacerbations associated with COPD | |
| JP3415643B2 (ja) | 筋ジストロフィー症治療薬 | |
| CA2458807A1 (en) | Use of atazanavir in hiv therapy | |
| Norris et al. | Trial of oral physostigmine in amyotrophic lateral sclerosis | |
| Wutzler et al. | Neuraminidase inhibitors in the treatment of influenza A and B–overview and case reports | |
| Buring et al. | Prevention of cardiovascular disease: risks and benefits of aspirin | |
| CN103635194B (zh) | 用于治疗早泄的药物组合物以及用于治疗早泄的方法 | |
| JP2002523363A5 (enExample) | ||
| Thakare et al. | An update on benznidazole for the treatment of patients with Chagas disease | |
| US20160166565A1 (en) | Treatment of multiple sclerosis with combination of laquinimod and flupirtine | |
| Abelson et al. | Ocular tolerability and safety of ketotifen fumarate ophthalmic solution | |
| GB2292081A (en) | The use of a Neuraminidase Inhibitor in combination with an Influenza Vaccine | |
| Demirtürk | COVID-19 Tedavisinde Kullanılan İlaçlar ve Farmakokinetiği | |
| EP3582786A1 (en) | Co-administration of minocycline and colistin to reduce acute kidney injury | |
| Kemper | Cardiac Effects of Bedaquiline and Delamanid in Combination |